English Journal

Mirimostim (macrophage colony-stimulating factor; M-CSF) improves chemotherapy-induced impaired natural killer cell activity, Th1/Th2 balance, and granulocyte function.

Hidaka T, Akada S, Teranishi A, Morikawa H, Sato S, Yoshida Y, Yajima A, Yaegashi N, Okamura K, Saito S.SourceDepartment of Obstetrics and Gynecology, Toyama Medical and Pharmaceutical University, Sugitani, Toyoma-shi, Toyama 930-0194, Japan. s30saito@ms.toyama-mpu.ac.jp
Cancer science.Cancer Sci.2003 Sep;94(9):814-20.
The purpose of this study was to clarify the effects of mirimostim (macrophage colony-stimulating factor; M-CSF) on immunological functions after chemotherapy. The percentage of natural killer (NK) cells in peripheral blood mononuclear cells (PBMCs), NK cell activity, T-helper cell 1/T-helper cell 2
PMID 12967481

Japanese Journal

Mirimostim (macrophage colony-stimulating factor ; M-CSF) improves chemotherapy-induced impaired natural killer cell activity, Th1/Th2 balance, and granulocyte function